LOADING
Comparing UnitedHealth Group (UNH) and Pfizer Inc (PFE), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | UNH | PFE |
|---|---|---|
| Price | $282.09 | $26.58 |
| Change Today | +1.82% | -1.04% |
| Market Cap | $256.0B | $151.1B |
| P/E Ratio | 21.3 | 19.5 |
| Forward P/E | 15.9 | 9.0 |
| PEG Ratio | 1.35 | 13.77 |
| EPS | $13.23 | $1.36 |
| Revenue Growth (YoY) | 12.3% | -1.2% |
| Profit Margin | 2.7% | 12.4% |
| Return on Equity | 12.5% | 8.9% |
| Dividend Yield | 3.15% | 6.40% |
| Beta | 0.38 | 0.41 |
| 52-Week High | $589.73 | $27.94 |
| 52-Week Low | $229.79 | $19.50 |
| Volume | 4.7M | 34.3M |
UnitedHealth Group is the larger company by market capitalization. Pfizer Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Pfizer Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.